Comments Submitted to FDA on Patient Preference Information – Submission, Review in PMAs, HDE Applications and De Novo Requests, and Inclusion in Device Labeling. (Docket Number: FDA-2015-D-1580-0001). Click here to read the comments and impact on ACRP Members.
Comments Submitted to The White House on Precision Medicine Initiative: Proposed Privacy and Trust Principles. Click here to read the comments.